About MicroRx
Infectious Disease Supercluster
Personnel
Contact Information
Advisory
Northern Colorado Infectious Disease Research
Colorado Bioscience
MicroRx Brochure
Partnering
Featured Research
Emerging Pathogen Threats
Food Safety
Mycobacterial Disease
Vector-borne Disease
Resources
Animal Models
Product Development and Manufacturing
Research Innovation Center
Rocky Mountain Regional Center for Excellence
Infectious Disease Research Center
For Researchers
CSU Superclusters
Activities
MicroRx Cluster Leaders
NeoTREX - Cancer Research
CENERGY - Clean Energy
Technology Transfer Process
Legal Agreements
CDA's
Consulting
IDF
Hybridoma Development Agreement
Contact Us
Email Registration
General Inquiry
MicroRx Technologies
Title of Technology
Compare all
tuberculosis technology summaries
in PDF format.
Differentiating Multiplex Assay for Listeria
Rice Blight Genomic Diagnostic
Immuno-Antimicrobial Therapy for Infection
Menaquinone A Inhibitors: Anti Mycobacterial Agents
Serodiagnostic Antigens for Tuberculosis
A Toll Receptor 2 Directed TB Vaccine
Acid and Base Stable Esters: New Linkers for Solid-Phase Organic Synthesis (
Synthesis
or
Libraries
)
Transferrin Receptor and Ferritin Expression in Primary Lung Lesions of Tuberculosis
A Drug-Sensitized Pseudomonas Aeruginosa Strain Useful for Drug Discovery
Asymmetrically Substituted Thiourea Derivatives: Potential Anti-TB Therapeutic Agents
Bovine Viral Diarrhea Virus (BVDV) Diagnostic for Early Detection of Infected Cows and Fetuses
Early Detection of Tuberculosis Using Culture Filtrate Proteins of Mycobacterium tuberculosis in Serological Assays
Blueport: Injectable Vaccine Portal
Active Sampling Device for Estimating Total Aerosol Deposition in the Human Respiratory Tract
Copyright © 2007 MicroRx. All rights reserved.